Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Evaluation by Community Health Agents of the attributes of Primary Health Care for fighting leprosy

Bolorino N, Gonçalves LC, Freitas FMBD, et al. Escola de Enfoermagem Aurora de Afonso Costa. Online Brazilian Journal of Nursing. 2024;
Download PDF
Publication

Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial

Hasker E, Assoumani Y, Randrianantoandro A, et al. Elsevier BV. The Lancet Global Health. 2024; 12 (6) : e1017-e1026.
Download PDF
Publication

A tribute to the elimination of leprosy

Das M. Elsevier BV. The Lancet Infectious Diseases. 2024;
Publication

Community-Based Intervention for Active Detection and Provision of Single-Dose Rifampicin Post-Exposure Prophylaxis to Household Contacts of Leprosy in Bolivia

Baptista Mora A, Ortuño-Gutiérrez N, Zurita Paniagua D, et al. MDPI AG. Tropical Medicine and Infectious Disease. 2024; 9 (5) : 1-12.
Download PDF
Publication

Global report on neglected tropical diseases 2024

World Health Organization . World Health Organization . 2024;
Download PDF
Publication

Zero Leprosy Strategic Plans: Global and National Level: A Short Communication

Geetha K. Medknow. Clinical Dermatology Review. 2024; 8 (2) : 167-170.
Download PDF
Publication

Leprosy identified in Sumba Island, eastern Indonesia: elimination targets under threat

Siregar GO, Harianja M, Adella J, et al. Elsevier BV. The Lancet Regional Health - Southeast Asia. 2024;
Download PDF
Publication

Using Passive Surveillance to Maintain Elimination as a Public Health Problem for Neglected Tropical Diseases: A Model-Based Exploration.

Minter A, Medley G, Hollingsworth DT. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024; 78 (Supplement_2) : S169-S174.
Download PDF
Publication

Sustainable development of leprosy elimination by 2030 in China

Liu J. Elsevier BV. The Lancet Regional Health - Western Pacific. 2024;
Download PDF
Publication

Hansen’s discovery of the Leprosy Bacillus: controversy over preventive measures in 19th Century British Colonial India

Desikan P, Pandya S. Lepra. Leprosy Review. 2024; 95 (1) : 118-123.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 9
  • Next page ››
Subscribe to Prevention of disease

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD